This month's Round Up includes updates with respect to the evidence base in hormone replacement therapy (HRT) as well as new prescribing guidance for Clostridium Associated Diarrhoea (CAD) and a summary of the "Target in Range" parameter used in Continuous Glucose Monitoring (CGM) for diabetes.